Purchases and Sales Made in Q3 2021 in Akari Therapeutics PLC (AKTX)
This table provides information about the institutional ownership of Akari Therapeutics PLC (AKTX) during Q3 2021. The information is specifically focused on institutions that hold shares of Akari Therapeutics Plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 15, 2021
Q3 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
15.3KNew |
$24.3K - $28.6K
|
15.3K
$15.3K
|
|
Nov 15, 2021
Q3 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
5.54KNew |
$8.81K - $10.4K
|
5.54K
$5.54K
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
BUY
|
- |
1.17KNew |
$1.87K - $2.19K
|
1.17K
$1.17K
|
|
Oct 06, 2021
Q3 2021
|
Ifp Advisors, Inc
|
SELL
|
- |
0Closed |
$0 - $0
|
0
$0
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-2.24K- 10.25% |
$3.56K - $4.18K
|
19.6K
$19.6K
|
|
Nov 12, 2021
Q3 2021
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-6K- 23.08% |
$9.54K - $11.2K
|
20K
$20K
|
|
Nov 15, 2021
Q3 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-14.5K- 27.73% |
$23K - $27.1K
|
37.8K
$37.8K
|
|
Nov 12, 2021
Q3 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-86K- 56.84% |
$137K - $161K
|
65.4K
$65.4K
|